Viewing Study NCT07207395


Ignite Creation Date: 2025-12-24 @ 2:12 PM
Ignite Modification Date: 2025-12-25 @ 12:51 PM
Study NCT ID: NCT07207395
Status: RECRUITING
Last Update Posted: 2025-10-06
First Post: 2025-10-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation.
Sponsor: The Christ Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module